A Phase I dose‐escalation study of DCLL9718S, an antibody‐drug conjugate targeting C‐type lectin‐like molecule‐1 (CLL‐1) in patients with acute myeloid leukemia. Issue 5 (11th March 2021) - Daver, Naval; Salhotra, Amandeep; Brandwein, Joseph M.; Podoltsev, Nikolai A.; Pollyea, Daniel A.; Jurcic, Joseph G.; Assouline, Sarit; Yee, Karen; Li, Mengsong; Pourmohamad, Tony; Samineni, Divya; Sumiyoshi, Teiko; et al.